Progression of Barrett's metaplasia to adenocarcinoma is accompanied by a range of genetic alterations (Fitzgerald and Triadafilopoulos, 1998; Jankowski et al, 1999; Jenkins et al, 2002), including loss of p53 tumour suppressor function. This evidence concerns the gene TP53 and adenocarcinoma.